What is BioConsortia worth?
$136.0Mlast known valuation
BioConsortia last raised $15.0M in its Early Stage VC (Apr 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for BioConsortia
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2023 | Early Stage VC | $15.0M | ▮ | ▮ |
| Mar 2019 | Early Stage VC | $8.0M | ▮ | ▮ |
| Mar 2018 | Early Stage VC | $10.0M | ▮ | ▮ |
| Oct 2016 | Early Stage VC | $8.0M | ▮ | ▮ |
How BioConsortia's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BioConsortia, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is BioConsortia worth?
- BioConsortia's last known valuation is $136.0M.
- How much has BioConsortia raised?
- BioConsortia has raised $79.0M in total funding across 4 recorded rounds.
- When did BioConsortia last raise?
- BioConsortia last raised in Apr 2023 (Early Stage VC), raising $15.0M.